Shape-sensing Robotic-Assisted Bronchoscopy with cone beam CT for the investigation of pulmonary nodules: interim results of the first multicentre European trial

<bold>Introduction:</bold> Shape-Sensing Robotic-Assisted Bronchoscopy (ssRAB) is a novel alternative to traditional biopsy techniques for diagnosing pulmonary nodules. Intraprocedural three-dimensional imaging with cone beam CT (CBCT) may improve device precision. This is the first multicentre European study to evaluate the Ion Endoluminal system (Intuitive Surgical, CA) with CBCT. <bold>Aims:</bold> To investigate the effectiveness of combining ssRAB with cone beam CT (CBCT) in the biopsy of pulmonary nodules. <bold>Methods:</bold> A single arm, multicentre prospective study enrolling 200 subjects with pulmonary nodules sized between 6 to 30mm for biopsy using ssRAB with CBCT. The primary outcome is radiological tool-in-lesion. We report the interim outcomes for the first 100 subjects. NCT number: 05867953 <bold>Results:</bold> 108 nodules were sampled in 100 subjects (mean age 68 years, 71% female). The median size of nodules was 13mm (IQR 11-18mm), mean distance was 20mm from the pleura and 29% nodules had a positive bronchus sign. The rate of tool in lesion was 99% (88% in central third and 12% in outer two-thirds of nodule). Median procedure time was 48 minutes; median total radiation dose 12 Gy/cm2. 80 nodules were confirmed as malignant with sufficient tissue for molecular testing in 98% where it was requested. 28 nodules remain under surveillance. Five serious adverse events occurred in four subjects including one (1%) pneumothorax requiring chest drain insertion. In addition, two (non-serious) bleeding events required intervention (2%). <bold>Conclusion:</bold> ssRAB combined with CBCT enables the precise placement of sampling tools within 99% of target pulmonary nodules.

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.oa2803
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Shape-sensing Robotic-Assisted Bronchoscopy with cone beam CT for the investigation of pulmonary nodules: interim results of the first multicentre European trial

Al‐Rehan Dhanji, Laura Avanzi, Christopher Michael Orton, Kire Temov et al.
1 links
Lung Cancer Diagnosis and Treatment
article

Shape-sensing Robotic-Assisted Bronchoscopy with cone beam CT for the investigation of pulmonary nodules: interim results of the first multicentre European trial

Al‐Rehan Dhanji, Laura Avanzi, Christopher Michael Orton, Kire Temov, Embiya Ağaoğlu, LT Chan, Inês Meireles, Justin Garner, Jennifer L. Moore, Anand Tana, Pallav L. Shah, Kelvin Lau, Eleanor Scott, Patrícia Pereira, Jessica L. Thomas, Aisha Kalyal, Maria Lapuente, Foteini Ttofia, Ilecia Baboolal, Ashish Karir
article en

Abstract

<bold>Introduction:</bold> Shape-Sensing Robotic-Assisted Bronchoscopy (ssRAB) is a novel alternative to traditional biopsy techniques for diagnosing pulmonary nodules. Intraprocedural three-dimensional imaging with cone beam CT (CBCT) may improve device precision. This is the first multicentre European study to evaluate the Ion Endoluminal system (Intuitive Surgical, CA) with CBCT. <bold>Aims:</bold> To investigate the effectiveness of combining ssRAB with cone beam CT (CBCT) in the biopsy of pulmonary nodules. <bold>Methods:</bold> A single arm, multicentre prospective study enrolling 200 subjects with pulmonary nodules sized between 6 to 30mm for biopsy using ssRAB with CBCT. The primary outcome is radiological tool-in-lesion. We report the interim outcomes for the first 100 subjects. NCT number: 05867953 <bold>Results:</bold> 108 nodules were sampled in 100 subjects (mean age 68 years, 71% female). The median size of nodules was 13mm (IQR 11-18mm), mean distance was 20mm from the pleura and 29% nodules had a positive bronchus sign. The rate of tool in lesion was 99% (88% in central third and 12% in outer two-thirds of nodule). Median procedure time was 48 minutes; median total radiation dose 12 Gy/cm2. 80 nodules were confirmed as malignant with sufficient tissue for molecular testing in 98% where it was requested. 28 nodules remain under surveillance. Five serious adverse events occurred in four subjects including one (1%) pneumothorax requiring chest drain insertion. In addition, two (non-serious) bleeding events required intervention (2%). <bold>Conclusion:</bold> ssRAB combined with CBCT enables the precise placement of sampling tools within 99% of target pulmonary nodules.

Barts Health NHS Trust (GB), Royal Brompton Hospital (GB), Lung Institute (US)
Openalex Percentile: Top 63%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.